Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes
Nan Wang1, Tong-Yu Xu2, Xu Zhang1
1Biopharmaceutical Lab, Life Science college, Northeast Agricultural University, Harbin 150030, China.
Abstract:
Type 2 diabetes mellitus (T2DM) is accompanied by abnormal glucose metabolism and low-grade chronic inflammation. Fibroblast growth factor 21 (FGF-21) is a novel metabolic regulator and can function as an endocrine hormone to regulate glucose and lipid metabolism. Recently, FGF-21 was found to have anti-inflammatory effect, to our knowledge, the effect of FGF-21 on inflammatory state in diabetes has not been elucidated. Here, we use db/db mice as a Type 2 diabetes model to determine whether FGF-21 alleviates inflammatory state while improves hyperglycemia. Our results demonstrated that FGF-21 not only showed potent long lasting hypoglycemic effect, but also demonstrated strong anti-inflammatory effect in the serum and white adipose tissue. Besides, in vitro experiments, insulin resistance (IR) was induced in 3T3-L1 adipocytes by treating with TNF-α. Our results showed that TNF-α impaired glucose metabolism of 3T3-L1 adipocytes but FGF-21 repressed gene expression of inflammatory factors caused by IR and consequently improved the glucose metabolism in 3T3-L1 adipocytes. Furthermore, FGF-21 ameliorated glucose uptake of TNF-α-induced IR in 3T3-L1 adipocytes by inhibiting NF-κB signaling pathway.
Insights
Fibroblast growth factor 21 (FGF-21) effectively lowers blood sugar and reduces inflammation in Type 2 diabetes models. FGF-21 improves glucose metabolism and combats inflammatory responses linked to insulin resistance.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Immunology
Background:
- Type 2 diabetes mellitus (T2DM) is characterized by impaired glucose metabolism and chronic inflammation.
- Fibroblast growth factor 21 (FGF-21) is a key metabolic regulator with potential anti-inflammatory properties.
- The specific impact of FGF-21 on the inflammatory state in diabetes remains largely uninvestigated.
Purpose of the Study:
- To investigate the effects of FGF-21 on hyperglycemia and inflammation in a Type 2 diabetes mouse model.
- To determine if FGF-21 can ameliorate insulin resistance and improve glucose metabolism in vitro.
Main Methods:
- Utilized db/db mice as a model for Type 2 diabetes.
- Administered FGF-21 to assess its impact on serum and white adipose tissue inflammatory markers.
- Induced insulin resistance in 3T3-L1 adipocytes using TNF-α for in vitro analysis.
- Examined the effect of FGF-21 on glucose metabolism and inflammatory gene expression in adipocytes.
- Investigated the role of the NF-κB signaling pathway in FGF-21's mechanism of action.
Main Results:
- FGF-21 demonstrated a potent and sustained hypoglycemic effect in db/db mice.
- Significant reduction in inflammatory markers was observed in both serum and white adipose tissue following FGF-21 treatment.
- In vitro, FGF-21 repressed the gene expression of inflammatory factors induced by TNF-α, thereby improving glucose metabolism in insulin-resistant adipocytes.
- FGF-21 enhanced glucose uptake in TNF-α-induced insulin-resistant adipocytes by inhibiting the NF-κB signaling pathway.
Conclusions:
- FGF-21 exhibits significant hypoglycemic and anti-inflammatory effects in the context of Type 2 diabetes.
- FGF-21 improves glucose metabolism and insulin resistance, partly through the inhibition of the NF-κB signaling pathway.
- These findings highlight FGF-21 as a potential therapeutic agent for managing both hyperglycemia and inflammation in Type 2 diabetes.
More Related Videos
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Inflammatory Response I: Vascular and Cellular


